JP5031762B2 - 分析方法と調査システム - Google Patents
分析方法と調査システム Download PDFInfo
- Publication number
- JP5031762B2 JP5031762B2 JP2008542634A JP2008542634A JP5031762B2 JP 5031762 B2 JP5031762 B2 JP 5031762B2 JP 2008542634 A JP2008542634 A JP 2008542634A JP 2008542634 A JP2008542634 A JP 2008542634A JP 5031762 B2 JP5031762 B2 JP 5031762B2
- Authority
- JP
- Japan
- Prior art keywords
- time
- measurement data
- time intervals
- derivative
- analyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004458 analytical method Methods 0.000 title claims description 19
- 238000005259 measurement Methods 0.000 claims description 58
- 239000012491 analyte Substances 0.000 claims description 42
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 36
- 239000008103 glucose Substances 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 32
- 230000000875 corresponding effect Effects 0.000 claims description 20
- 210000001124 body fluid Anatomy 0.000 claims description 17
- 239000010839 body fluid Substances 0.000 claims description 17
- 230000009466 transformation Effects 0.000 claims description 17
- 241001465754 Metazoa Species 0.000 claims description 16
- 208000024891 symptom Diseases 0.000 claims description 15
- 201000010099 disease Diseases 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 230000004060 metabolic process Effects 0.000 claims description 12
- 238000004364 calculation method Methods 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 10
- 230000004153 glucose metabolism Effects 0.000 claims description 6
- 230000002596 correlated effect Effects 0.000 claims description 5
- 230000002045 lasting effect Effects 0.000 claims description 5
- 208000030159 metabolic disease Diseases 0.000 claims description 4
- 230000002503 metabolic effect Effects 0.000 claims description 4
- 208000016097 disease of metabolism Diseases 0.000 claims description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 46
- 206010012601 diabetes mellitus Diseases 0.000 description 27
- 102000004877 Insulin Human genes 0.000 description 23
- 108090001061 Insulin Proteins 0.000 description 23
- 229940125396 insulin Drugs 0.000 description 23
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 238000007726 management method Methods 0.000 description 13
- 235000012054 meals Nutrition 0.000 description 7
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 4
- 230000008844 regulatory mechanism Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 230000037406 food intake Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 230000002618 waking effect Effects 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031942 Late Onset disease Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- -1 interstitial fluid Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001019 normoglycemic effect Effects 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05026421.7A EP1793321B1 (de) | 2005-12-03 | 2005-12-03 | Auswerteverfahren und Untersuchungssystem eines Analyten im Körperflüssigkeit eines Menschen oder Tieres |
| EP05026421.7 | 2005-12-03 | ||
| PCT/EP2006/011089 WO2007062755A1 (de) | 2005-12-03 | 2006-11-18 | Auswerteverfahren und untersuchungssystem |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009519048A JP2009519048A (ja) | 2009-05-14 |
| JP2009519048A5 JP2009519048A5 (enExample) | 2009-11-26 |
| JP5031762B2 true JP5031762B2 (ja) | 2012-09-26 |
Family
ID=35965935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542634A Expired - Fee Related JP5031762B2 (ja) | 2005-12-03 | 2006-11-18 | 分析方法と調査システム |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8734347B2 (enExample) |
| EP (2) | EP1793321B1 (enExample) |
| JP (1) | JP5031762B2 (enExample) |
| DK (1) | DK1793321T3 (enExample) |
| ES (1) | ES2609385T3 (enExample) |
| WO (1) | WO2007062755A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
| EP2071339A3 (en) * | 2007-12-12 | 2015-05-20 | Sysmex Corporation | System for providing animal test information and method of providing animal test information |
| US8657746B2 (en) * | 2010-10-28 | 2014-02-25 | Medtronic Minimed, Inc. | Glucose sensor signal purity analysis |
| EP3434184B1 (en) * | 2014-04-10 | 2021-10-27 | DexCom, Inc. | Glycemic urgency assessment and alerts interface |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4221848C2 (de) | 1992-07-03 | 2001-04-12 | Eckhard Salzsieder | Verfahren und Anordnung zur selbsttätigen in situ Kalibrierung von intrakorporalen Glukosemeßeinrichtungen |
| US7624028B1 (en) * | 1992-11-17 | 2009-11-24 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
| EP0910023A2 (de) | 1997-10-17 | 1999-04-21 | Siemens Aktiengesellschaft | Verfahren und Anordnung zur neuronalen Modellierung eines dynamischen Systems mit nichtlinearem stochastischem Verhalten |
| JP3692751B2 (ja) * | 1997-12-24 | 2005-09-07 | 松下電器産業株式会社 | 糖尿病判断機能付き血糖計 |
| JPH11318872A (ja) * | 1998-05-18 | 1999-11-24 | Matsushita Electric Ind Co Ltd | 糖尿病判断機能付き血糖計 |
| US6925393B1 (en) | 1999-11-18 | 2005-08-02 | Roche Diagnostics Gmbh | System for the extrapolation of glucose concentration |
| JP2001212114A (ja) * | 2000-02-02 | 2001-08-07 | Matsushita Electric Ind Co Ltd | 血糖計 |
| US7890295B2 (en) * | 2000-02-23 | 2011-02-15 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
| EP1309271B1 (en) * | 2000-08-18 | 2008-04-16 | Animas Technologies LLC | Device for prediction of hypoglycemic events |
| KR20030031894A (ko) * | 2001-02-05 | 2003-04-23 | 글루코센스 인코퍼레이티드 | 혈중 포도당 농도의 측정 방법 |
| US7399277B2 (en) * | 2001-12-27 | 2008-07-15 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
| EP2301428B1 (en) * | 2003-12-09 | 2016-11-30 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
-
2005
- 2005-12-03 ES ES05026421.7T patent/ES2609385T3/es not_active Expired - Lifetime
- 2005-12-03 EP EP05026421.7A patent/EP1793321B1/de not_active Expired - Lifetime
- 2005-12-03 DK DK05026421.7T patent/DK1793321T3/en active
-
2006
- 2006-11-18 WO PCT/EP2006/011089 patent/WO2007062755A1/de not_active Ceased
- 2006-11-18 EP EP06818656A patent/EP1955232A1/de not_active Withdrawn
- 2006-11-18 JP JP2008542634A patent/JP5031762B2/ja not_active Expired - Fee Related
-
2008
- 2008-05-30 US US12/130,091 patent/US8734347B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1793321A1 (de) | 2007-06-06 |
| ES2609385T3 (es) | 2017-04-20 |
| EP1955232A1 (de) | 2008-08-13 |
| DK1793321T3 (en) | 2017-01-16 |
| WO2007062755A1 (de) | 2007-06-07 |
| US8734347B2 (en) | 2014-05-27 |
| US20080262333A1 (en) | 2008-10-23 |
| JP2009519048A (ja) | 2009-05-14 |
| EP1793321B1 (de) | 2016-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007014751A (ja) | インスリン投与量調節のために糖尿病患者の体液について一連のグルコース濃度を評価する方法と装置 | |
| Mazze et al. | Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis | |
| US11096611B2 (en) | Method for providing a signal quality degree associated with an analyte value measured in a continuous monitoring system | |
| US20200152335A1 (en) | Method for the Detection and Handling of Hypoglycemia | |
| JP5661651B2 (ja) | 低血糖のリスク査定およびなだらかなインスリン放出の減少による、cgmに基づいた低血糖の予防 | |
| TW592666B (en) | Use of targeted glycemic profiles in the calibration of a noninvasive blood glucose monitor | |
| US20090240440A1 (en) | Non-Invasive Glucose Monitoring | |
| Celis et al. | Self-measurement of blood pressure at home in the management of hypertension | |
| EP2893878A1 (en) | Bioinformation processing system, wearable device, server system, and control method and program for bioinformation processing system | |
| EP2217135B1 (en) | Assessing residual insulin time | |
| JP2010519537A (ja) | 頻繁な血中グルコースの入力を使用する炭水化物比率検査 | |
| WO2005067788A1 (en) | Determination of glucose sensitivity and a method to manipulate blood glucose concentration | |
| CN113063753B (zh) | 一种基于近红外光的血糖预测模型自校正方法 | |
| Kolodyazhniy et al. | Estimation of human circadian phase via a multi-channel ambulatory monitoring system and a multiple regression model | |
| Bellia et al. | Exercise individualized by TRIMPi method reduces arterial stiffness in early onset type 2 diabetic patients: a randomized controlled trial with aerobic interval training | |
| Romero-Ugalde et al. | ARX model for interstitial glucose prediction during and after physical activities | |
| CN110786865A (zh) | 使用个性化直方图来控制血液葡萄糖的系统及方法 | |
| Giani et al. | Performance of the Flash Glucose Monitoring System during exercise in youth with Type 1 diabetes | |
| Vettoretti et al. | Modeling the error of factory-calibrated continuous glucose monitoring sensors: application to Dexcom G6 sensor data | |
| JP2017533495A (ja) | 健康関連の問題の管理のためのスマートロギング | |
| US8734347B2 (en) | Analytical method and investigation system | |
| Boscari et al. | Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor | |
| Cescon et al. | Linear modeling and prediction in diabetes physiology | |
| CN117558435B (zh) | 一种基于bcm设备的远程透析指导系统 | |
| Silva et al. | Association of cardiac autonomic modulation with physical and clinical features of young people with type 1 diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091006 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091006 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20100525 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120117 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120417 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120612 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120627 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5031762 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150706 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |